Symbiomics, a Brazilian biotechnology company developing microbiome solutions for more sustainable agriculture, has announced that it has successfully closed its Series A funding round with an equity investment led by Corteva through its investment and collaboration platform Corteva Catalyst. According to a news release, Corteva will collaborate with Symbiomics to discover novel microbial solutions for better crop health and increased yields. The companies will explore applications of Symbiomics’ proprietary genomics discovery platform and its microbial strains with unique traits to develop new solutions for farmers worldwide. “The investment from Corteva represents an important recognition of Symbiomics as a company committed to developing innovative technologies for agribusiness,” said Rafael de Souza, co-founder and CEO for Symbiomics, in a prepared statement. “The Series A funding and Corteva collaboration will enable us to accelerate these developments and strengthen our position across the sector.” The funding round also includes investments from existing investors Arar Capital, Cazanga, MOV Investimentos and The Yield Lab Latam. With the investment round secured, the company will continue to advance its discovery of novel microbes and development of technology based on genome editing and trait discovery. The funding will also help accelerate the company’s go-to-market timeline through strategic partnerships across the agribusiness sector.
